On the T cell side, CAR T cells remained activated as shown with CD25 expression, and they displayed increased expression of immune checkpoint TIM-3 and LAG-3 and compromised cytotoxicity after their engagement with PDA cells in vitro. The gene discussed is HAVCR2; the disease is Patent ductus arteriosus.